The low dose of the Pfizer BioNTech vaccine is safe and effective in children aged 5 to 11 years

Among the 12 to 17 year olds who have been eligible since the Pfizer BioNTech shot Can, only about half according to the American Academy of Pediatrics, received at least one dose. More than 5 million cases of Covid-19, the disease caused by the coronavirus, have been reported in children and adolescents, which has caused 20,000 hospitalizations and 460 deaths since the pandemic began. Lots of families and schools have navigated disruptive quarantines and sometimes divisive guidelines on the use of masks.

Leave a Comment